Skip to content

HEMAGEN DIAGNOSTICS INC: 10-Q filed 2012-08-14

What HEMAGEN DIAGNOSTICS INC reported in its quarterly report filed 2012-08-14 (fiscal Q3 2012): 36 published measures, 98 facts as tagged in accession 0001445866-12-000603.

This filing

Form
10-Q (quarterly report)
Filed
2012-08-14
Fiscal period
fiscal Q3 2012
Accession
0001445866-12-000603 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HEMAGEN DIAGNOSTICS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-06-302,521,487USD
At 2011-09-302,888,302USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-06-305,955,579USD
At 2011-09-305,575,372USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-06-30-3,434,092USD
At 2011-09-30-2,687,070USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-06-30107,308USD
At 2011-09-30213,611USD
At 2011-06-30209,933USD
At 2010-09-30151,743USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-132,132USD91
2011-10-01 to 2012-06-30-744,332USD274
2011-04-01 to 2011-06-30-48,084USD91
2010-10-01 to 2011-06-30-598,597USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-10-01 to 2012-06-30-307,849USD274
2010-10-01 to 2011-06-30-402,210USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-10-01 to 2012-06-30307,455USD274
2010-10-01 to 2011-06-30271,413USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-10-01 to 2012-06-30-52,473USD274
2010-10-01 to 2011-06-30120,950USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-06-30-26,515,248USD
At 2011-09-30-25,770,916USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-04-01 to 2012-06-3015,498,962shares91
2011-10-01 to 2012-06-3015,494,880shares274
2011-04-01 to 2011-06-3015,478,907shares91
2010-10-01 to 2011-06-3015,473,743shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-04-01 to 2012-06-3015,498,962shares91
2011-10-01 to 2012-06-3015,494,880shares274
2011-04-01 to 2011-06-3015,478,907shares91
2010-10-01 to 2011-06-3015,473,743shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-0.01USD/shares91
2011-10-01 to 2012-06-30-0.05USD/shares274
2011-04-01 to 2011-06-300USD/shares91
2010-10-01 to 2011-06-30-0.04USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-0.01USD/shares91
2011-10-01 to 2012-06-30-0.05USD/shares274
2011-04-01 to 2011-06-300USD/shares91
2010-10-01 to 2011-06-30-0.04USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2010-10-01 to 2011-06-304,132USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-06-30312,190USD
At 2011-09-30386,520USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-10-01 to 2012-06-3035,504USD274
2010-10-01 to 2011-06-3034,410USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-12,303USD91
2011-10-01 to 2012-06-30-394,209USD274
2011-04-01 to 2011-06-3060,207USD91
2010-10-01 to 2011-06-30-303,264USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-06-302,144,157USD
At 2011-09-302,449,124USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-06-301,905,721USD
At 2011-09-301,525,514USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-04-01 to 2012-06-30465,758USD91
2011-10-01 to 2012-06-301,605,525USD274
2011-04-01 to 2011-06-30607,363USD91
2010-10-01 to 2011-06-301,796,172USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-06-301,366,796USD
At 2011-09-301,460,780USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-04-01 to 2012-06-30453,455USD91
2011-10-01 to 2012-06-301,211,316USD274
2011-04-01 to 2011-06-30667,570USD91
2010-10-01 to 2011-06-301,492,908USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-04-01 to 2012-06-30465,275USD91
2011-10-01 to 2012-06-301,578,998USD274
2011-04-01 to 2011-06-30605,997USD91
2010-10-01 to 2011-06-301,792,277USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-04-01 to 2012-06-30483USD91
2011-10-01 to 2012-06-3026,527USD274
2011-04-01 to 2011-06-301,366USD91
2010-10-01 to 2011-06-303,895USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-06-3015,600,281shares
At 2011-09-3015,585,281shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-06-3023,109,834USD
At 2011-09-3023,038,217USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-06-306,456,041USD
At 2011-09-306,431,680USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-06-3084,718USD
At 2011-09-30159,493USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-10-01 to 2012-06-30-744,332USD274
2010-10-01 to 2011-06-30-598,597USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-213,438USD91
2011-10-01 to 2012-06-30-818,788USD274
2011-04-01 to 2011-06-306,729USD91
2010-10-01 to 2011-06-30-505,001USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-10-01 to 2012-06-30127,688USD274
2010-10-01 to 2011-06-30141,422USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-16USD91
2011-10-01 to 2012-06-301,009USD274
2011-04-01 to 2011-06-30198USD91
2010-10-01 to 2011-06-30128USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-04-01 to 2012-06-30-119,829USD91
2011-10-01 to 2012-06-30-350,123USD274
2011-04-01 to 2011-06-30-108,291USD91
2010-10-01 to 2011-06-30-291,201USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2010-10-01 to 2011-06-303,011USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-10-01 to 2012-06-30-5,294USD274
2010-10-01 to 2011-06-3025,766USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-10-01 to 2012-06-30104,726USD274
2010-10-01 to 2011-06-30-92,714USD273

Inspect the source

Entity
HEMAGEN DIAGNOSTICS INC / CIK 0000892822
Captured
SEC response SHA-256
66921f87da4e0d86dffa3310999789de19d5bb59093e2b9e10f65f5dea1f7b7b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000892822.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))